Jane Street’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
Other funds holding LXEO
Jane Street's LXEO Position: Q3 2026 in Review
Jane Street opened a new position in Lexeo Therapeutics (LXEO) in Q3 2026: 183,283 shares worth $619K. The stake represents ﹤0.01% of the portfolio and ranks #7527 among its holdings. This is a return to the name: Jane Street previously reported a position in LXEO as recently as Q4 2025.
Jane Street first reported a position in LXEO in Q4 2023 and has held it in 8 quarters since. The position peaked at $1.39M in Q4 2025. 153 funds tracked by Wall St. Rank hold LXEO as of Q3 2026.
- Jane Street held 183,283 shares of Lexeo Therapeutics worth $619K as of Q3 2026.
- Lexeo Therapeutics was a new Jane Street position in Q3 2026.
- Lexeo Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #7527 holding.
- Jane Street first reported a position in Lexeo Therapeutics in Q4 2023 and has held it in 8 quarters since.
- Jane Street's Lexeo Therapeutics position peaked at $1.39M in Q4 2025.
- 153 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.